{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:13:24Z","timestamp":1784546004489,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.metabol.2021.154862","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T03:53:43Z","timestamp":1628394823000},"page":"154862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Ischemic heart failure mortality is not predicted by cardiac insulin resistance but by diabetes per se and coronary flow reserve: A retrospective dynamic cardiac 18F-FDG PET study"],"prefix":"10.1016","volume":"123","author":[{"given":"Thien Vinh","family":"Luong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette Glavind B\u00fclow","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette Louise Blouner Gram","family":"Kj\u00e6rulff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrine Meyer","family":"Lauritsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Poulsen","family":"Tolbod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esben","family":"S\u00f8ndergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Christian","family":"Gormsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.metabol.2021.154862_bb0005","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.dsx.2019.02.023","article-title":"Insulin resistance is a cardiovascular risk factor in humans","volume":"13","author":"Adeva-Andany","year":"2019","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"10.1016\/j.metabol.2021.154862_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10741-015-9515-6","article-title":"Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes","volume":"21","author":"Patel","year":"2016","journal-title":"Heart Fail Rev"},{"issue":"1","key":"10.1016\/j.metabol.2021.154862_bb0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12350-016-0586-0","article-title":"Heart failure, whole-body insulin resistance and myocardial insulin resistance: an intriguing puzzle","volume":"25","author":"Gargiulo","year":"2018","journal-title":"J Nucl Cardiol"},{"issue":"3","key":"10.1016\/j.metabol.2021.154862_bb0020","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.hfc.2019.02.002","article-title":"Glucose metabolism abnormalities in heart failure patients: insights and prognostic relevance","volume":"15","author":"Marsico","year":"2019","journal-title":"Heart Fail Clin"},{"issue":"5","key":"10.1016\/j.metabol.2021.154862_bb0025","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1530\/EJE-17-0882","article-title":"Insulin-stimulated glucose uptake in skeletal muscle, adipose tissue and liver: a positron emission tomography study","volume":"178","author":"Honka","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.metabol.2021.154862_bb0030","first-page":"1116","article-title":"Insulin action on heart and skeletal muscle FDG uptake in patients with hypertriglyceridemia","volume":"40","author":"Yokoyama","year":"1999","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.metabol.2021.154862_bb0035","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s001250050946","article-title":"Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM","volume":"41","author":"Utriainen","year":"1998","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.metabol.2021.154862_bb0040","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/j.semnuclmed.2020.02.010","article-title":"Myocardial viability testing by positron emission tomography: basic concepts, Mini-review of the literature and experience from a tertiary PET center","volume":"50","author":"Madsen","year":"2020","journal-title":"Semin Nucl Med"},{"issue":"1","key":"10.1016\/j.metabol.2021.154862_bb0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12350-016-0622-0","article-title":"Heart failure patients with prediabetes and newly diagnosed diabetes display abnormalities in myocardial metabolism","volume":"25","author":"Nielsen","year":"2018","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"10.1016\/j.metabol.2021.154862_bb0050","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0735-1097(00)01088-3","article-title":"Early assessment of regional myocardial blood flow and metabolism in thrombolysis in myocardial infarction flow grade 3 reperfused myocardial infarction using carbon-11-acetate","volume":"37","author":"Maes","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.metabol.2021.154862_bb0055","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJM199407283310402","article-title":"Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction","volume":"331","author":"Uren","year":"1994","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.metabol.2021.154862_bb0060","doi-asserted-by":"crossref","first-page":"E1122","DOI":"10.1152\/ajpendo.2000.279.5.E1122","article-title":"Lumped constant for [(18)F]fluorodeoxyglucose in skeletal muscles of obese and nonobese humans","volume":"279","author":"Peltoniemi","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.metabol.2021.154862_bb0065","first-page":"1798","article-title":"Determination of the lumped constant for [18F] fluorodeoxyglucose in human skeletal muscle","volume":"40","author":"Kelley","year":"1999","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1016\/j.metabol.2021.154862_bb0070","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nm.4350","article-title":"Insulin action and resistance in obesity and type 2 diabetes","volume":"23","author":"Czech","year":"2017","journal-title":"Nat Med"},{"issue":"Suppl. 2","key":"10.1016\/j.metabol.2021.154862_bb0075","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.2337\/dc09-S302","article-title":"Skeletal muscle insulin resistance is the primary defect in type 2 diabetes","volume":"32","author":"DeFronzo","year":"2009","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.metabol.2021.154862_bb0080","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2337\/dc16-0330","article-title":"CV protection in the EMPA-REG OUTCOME trial: a \u201cthrifty substrate\u201d hypothesis","volume":"39","author":"Ferrannini","year":"2016","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.metabol.2021.154862_bb0085","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.bbamcr.2011.01.015","article-title":"Targeting fatty acid and carbohydrate oxidation\u2013a novel therapeutic intervention in the ischemic and failing heart","volume":"1813","author":"Jaswal","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.metabol.2021.154862_bb0090","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1006\/jmcc.1999.0952","article-title":"Effect of transient ischemia on the expression of glucose transporters GLUT-1 and GLUT-4 in rat myocardium","volume":"31","author":"Tardy-Cantalupi","year":"1999","journal-title":"J Mol Cell Cardiol"},{"issue":"12","key":"10.1016\/j.metabol.2021.154862_bb0095","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s00259-019-04471-9","article-title":"Clinical significance of quantitative assessment of right ventricular glucose metabolism in patients with heart failure with reduced ejection fraction","volume":"46","author":"Tsai","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.metabol.2021.154862_bb0100","first-page":"838","article-title":"Metabolic modulators in heart disease: past, present, and future","volume":"33","author":"Lopaschuk","year":"2017","journal-title":"Can J Cardiol"},{"issue":"8","key":"10.1016\/j.metabol.2021.154862_bb0105","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/bph.12475","article-title":"Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy","volume":"171","author":"Fillmore","year":"2014","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.metabol.2021.154862_bb0110","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s12350-010-9228-0","article-title":"An abbreviated hyperinsulinemic-euglycemic clamp results in similar myocardial glucose utilization in both diabetic and non-diabetic patients with ischemic cardiomyopathy","volume":"17","author":"Fallavollita","year":"2010","journal-title":"J Nucl Cardiol"},{"issue":"12","key":"10.1016\/j.metabol.2021.154862_bb0115","first-page":"2064","article-title":"Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography","volume":"34","author":"Voipio-Pulkki","year":"1993","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1016\/j.metabol.2021.154862_bb0120","first-page":"1730","article-title":"Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction","volume":"42","author":"Vitale","year":"2001","journal-title":"J Nucl Med"},{"issue":"8","key":"10.1016\/j.metabol.2021.154862_bb0125","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1055\/a-0643-4739","article-title":"Altered glucose uptake in muscle, visceral adipose tissue, and brain predict whole-body insulin resistance and may contribute to the development of type 2 diabetes: a combined PET\/MR study","volume":"50","author":"Boersma","year":"2018","journal-title":"Horm Metab Res"},{"issue":"1","key":"10.1016\/j.metabol.2021.154862_bb0130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1148\/radiol.2017162949","article-title":"Whole-body imaging of tissue-specific insulin sensitivity and body composition by using an integrated PET\/MR system: a feasibility study","volume":"286","author":"Johansson","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.metabol.2021.154862_bb0135","doi-asserted-by":"crossref","first-page":"154168","DOI":"10.1016\/j.metabol.2020.154168","article-title":"Normalization of metabolic flux data during clamp studies in humans","volume":"104","author":"Ter Horst","year":"2020","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.metabol.2021.154862_bb0140","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1007\/s00125-013-2976-z","article-title":"Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study","volume":"56","author":"Tripathy","year":"2013","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.metabol.2021.154862_bb0145","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/dc14-2989","article-title":"Sclerostin and insulin resistance in Prediabetes: evidence of a cross talk between bone and glucose metabolism","volume":"38","author":"Daniele","year":"2015","journal-title":"Diabetes Care"},{"issue":"7533","key":"10.1016\/j.metabol.2021.154862_bb0150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/bmj.38678.389583.7C","article-title":"Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies","volume":"332","author":"Huxley","year":"2006","journal-title":"Bmj"},{"issue":"6","key":"10.1016\/j.metabol.2021.154862_bb0155","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/ije\/25.6.1250","article-title":"Mortality during 25 years of follow-up of a cohort with diabetes","volume":"25","author":"Swerdlow","year":"1996","journal-title":"Int J Epidemiol"},{"issue":"4","key":"10.1016\/j.metabol.2021.154862_bb0160","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2337\/dc07-2124","article-title":"Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects","volume":"31","author":"Juutilainen","year":"2008","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.metabol.2021.154862_bb0165","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/ejhf.1202","article-title":"Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study","volume":"20","author":"Iorio","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10.1016\/j.metabol.2021.154862_bb0170","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/ejhf.813","article-title":"Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC heart failure long-term registry","volume":"19","author":"Chioncel","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.metabol.2021.154862_bb0175","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s10741-019-09804-2","article-title":"Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target","volume":"24","author":"Manolis","year":"2019","journal-title":"Heart Fail Rev"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521001621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521001621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:28:24Z","timestamp":1758428904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049521001621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":35,"alternative-id":["S0026049521001621"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154862","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ischemic heart failure mortality is not predicted by cardiac insulin resistance but by diabetes per se and coronary flow reserve: A retrospective dynamic cardiac 18F-FDG PET study","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"154862"}}